Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

Anti-T2 biological therapies have proven to effectively reduce acute exacerbations and daily doses of oral steroids in severe eosinophilic asthma. Despite the remarkable clinical efficacy, there are usually only moderate improvements in airflow limitation, suggesting that other measures of lung func...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Abdo, Mustafa (VerfasserIn) , Watz, Henrik (VerfasserIn) , Veith, Vera (VerfasserIn) , Kirsten, Anne-Marie (VerfasserIn) , Biller, Heike (VerfasserIn) , Pedersen, Frauke (VerfasserIn) , Mutius, Erika von (VerfasserIn) , Kopp, Matthias (VerfasserIn) , Hansen, Gesine (VerfasserIn) , Waschki, Benjamin (VerfasserIn) , Rabe, Klaus F. (VerfasserIn) , Trinkmann, Frederik (VerfasserIn) , Bahmer, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 October 2020
In: Respiratory research
Year: 2020, Jahrgang: 21
ISSN:1465-993X
DOI:10.1186/s12931-020-01543-5
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12931-020-01543-5
Volltext
Verfasserangaben:Mustafa Abdo, Henrik Watz, Vera Veith, Anne-Marie Kirsten, Heike Biller, Frauke Pedersen, Erika von Mutius, Matthias V. Kopp, Gesine Hansen, Benjamin Waschki, Klaus F. Rabe, Frederik Trinkmann and Thomas Bahmer

MARC

LEADER 00000caa a2200000 c 4500
001 1741176301
003 DE-627
005 20230427164355.0
007 cr uuu---uuuuu
008 201126s2020 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12931-020-01543-5  |2 doi 
035 |a (DE-627)1741176301 
035 |a (DE-599)KXP1741176301 
035 |a (OCoLC)1341382524 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Abdo, Mustafa  |e VerfasserIn  |0 (DE-588)1222185571  |0 (DE-627)1741178037  |4 aut 
245 1 0 |a Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma  |b a longitudinal observational study  |c Mustafa Abdo, Henrik Watz, Vera Veith, Anne-Marie Kirsten, Heike Biller, Frauke Pedersen, Erika von Mutius, Matthias V. Kopp, Gesine Hansen, Benjamin Waschki, Klaus F. Rabe, Frederik Trinkmann and Thomas Bahmer 
264 1 |c 21 October 2020 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.11.2020 
520 |a Anti-T2 biological therapies have proven to effectively reduce acute exacerbations and daily doses of oral steroids in severe eosinophilic asthma. Despite the remarkable clinical efficacy, there are usually only moderate improvements in airflow limitation, suggesting that other measures of lung function like small airway dysfunction (SAD) might better reflect the clinical response. We aimed to investigate if measures of small airway function would predict and correlate with the clinical response to anti-T2 therapy. 
700 1 |a Watz, Henrik  |d 1971-  |e VerfasserIn  |0 (DE-588)124250815  |0 (DE-627)085737321  |0 (DE-576)294088156  |4 aut 
700 1 |a Veith, Vera  |e VerfasserIn  |4 aut 
700 1 |a Kirsten, Anne-Marie  |d 1972-  |e VerfasserIn  |0 (DE-588)121500861  |0 (DE-627)081348819  |0 (DE-576)292742576  |4 aut 
700 1 |a Biller, Heike  |d 1974-  |e VerfasserIn  |0 (DE-588)122626249  |0 (DE-627)705975975  |0 (DE-576)293354200  |4 aut 
700 1 |a Pedersen, Frauke  |e VerfasserIn  |4 aut 
700 1 |a Mutius, Erika von  |d 1957-  |e VerfasserIn  |0 (DE-588)1046090887  |0 (DE-627)775709034  |0 (DE-576)399380426  |4 aut 
700 1 |a Kopp, Matthias  |d 1965-  |e VerfasserIn  |0 (DE-588)130005657  |0 (DE-627)486919404  |0 (DE-576)297946307  |4 aut 
700 1 |a Hansen, Gesine  |d 1965-  |e VerfasserIn  |0 (DE-588)123107334  |0 (DE-627)082351414  |0 (DE-576)293558876  |4 aut 
700 1 |a Waschki, Benjamin  |d 1980-  |e VerfasserIn  |0 (DE-588)1044034289  |0 (DE-627)771293348  |0 (DE-576)396649076  |4 aut 
700 1 |a Rabe, Klaus F.  |e VerfasserIn  |0 (DE-588)142581453  |0 (DE-627)637305477  |0 (DE-576)33220054X  |4 aut 
700 1 |a Trinkmann, Frederik  |d 1983-  |e VerfasserIn  |0 (DE-588)142731773  |0 (DE-627)704298066  |0 (DE-576)332907406  |4 aut 
700 1 |a Bahmer, Thomas  |d 1985-  |e VerfasserIn  |0 (DE-588)1013173864  |0 (DE-627)663816947  |0 (DE-576)346657571  |4 aut 
773 0 8 |i Enthalten in  |t Respiratory research  |d London : BioMed Central, 2001  |g 21(2020) Artikel-Nummer 278, 7 Seiten  |h Online-Ressource  |w (DE-627)326646485  |w (DE-600)2041675-1  |w (DE-576)107014823  |x 1465-993X  |7 nnas  |a Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma a longitudinal observational study 
773 1 8 |g volume:21  |g year:2020  |g extent:7  |a Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma a longitudinal observational study 
856 4 0 |u https://doi.org/10.1186/s12931-020-01543-5  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201126 
993 |a Article 
994 |a 2020 
998 |g 142731773  |a Trinkmann, Frederik  |m 142731773:Trinkmann, Frederik  |d 910000  |d 950000  |d 950900  |d 60000  |d 61000  |e 910000PT142731773  |e 950000PT142731773  |e 950900PT142731773  |e 60000PT142731773  |e 61000PT142731773  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/60000/  |k 1/60000/61000/  |p 12 
999 |a KXP-PPN1741176301  |e 3813290883 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 26.11.2020"],"language":["eng"],"person":[{"role":"aut","family":"Abdo","display":"Abdo, Mustafa","given":"Mustafa"},{"given":"Henrik","display":"Watz, Henrik","role":"aut","family":"Watz"},{"role":"aut","family":"Veith","display":"Veith, Vera","given":"Vera"},{"role":"aut","family":"Kirsten","display":"Kirsten, Anne-Marie","given":"Anne-Marie"},{"given":"Heike","role":"aut","family":"Biller","display":"Biller, Heike"},{"given":"Frauke","display":"Pedersen, Frauke","family":"Pedersen","role":"aut"},{"given":"Erika von","display":"Mutius, Erika von","family":"Mutius","role":"aut"},{"given":"Matthias","family":"Kopp","role":"aut","display":"Kopp, Matthias"},{"given":"Gesine","role":"aut","family":"Hansen","display":"Hansen, Gesine"},{"display":"Waschki, Benjamin","family":"Waschki","role":"aut","given":"Benjamin"},{"given":"Klaus F.","display":"Rabe, Klaus F.","family":"Rabe","role":"aut"},{"display":"Trinkmann, Frederik","family":"Trinkmann","role":"aut","given":"Frederik"},{"given":"Thomas","display":"Bahmer, Thomas","family":"Bahmer","role":"aut"}],"id":{"doi":["10.1186/s12931-020-01543-5"],"eki":["1741176301"]},"recId":"1741176301","type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Mustafa Abdo, Henrik Watz, Vera Veith, Anne-Marie Kirsten, Heike Biller, Frauke Pedersen, Erika von Mutius, Matthias V. Kopp, Gesine Hansen, Benjamin Waschki, Klaus F. Rabe, Frederik Trinkmann and Thomas Bahmer"]},"origin":[{"dateIssuedDisp":"21 October 2020","dateIssuedKey":"2020"}],"relHost":[{"pubHistory":["1.2000 -"],"note":["Gesehen am 04.08.22"],"language":["eng"],"id":{"issn":["1465-993X"],"zdb":["2041675-1"],"eki":["326646485"]},"recId":"326646485","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma a longitudinal observational studyRespiratory research","origin":[{"publisher":"BioMed Central","dateIssuedDisp":"2001-","publisherPlace":"London","dateIssuedKey":"2001"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Respiratory research","title_sort":"Respiratory research"}],"part":{"extent":"7","volume":"21","text":"21(2020) Artikel-Nummer 278, 7 Seiten","year":"2020"}}],"physDesc":[{"extent":"7 S."}],"title":[{"subtitle":"a longitudinal observational study","title_sort":"Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma","title":"Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma"}]} 
SRT |a ABDOMUSTAFSMALLAIRWA2120